Amylyx Pharmaceuticals, Inc. (AMLX) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Amylyx Pharmaceuticals, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -7.89x | -0.85x | 20.09x | -12.39x | -11.89x | -24.13x |
| P/B Ratio | 3.74x | 1.56x | 2.28x | 7.22x | -6.92x | -15.29x |
| P/S Ratio | 0.00x | 2.95x | 2.60x | 110.55x | 0.00x | 1569.76x |
| Profitability | ||||||
| Gross Margin | 0.0% | 51.8% | 93.3% | 86.5% | 0.0% | -3683.7% |
| Operating Margin | 0.0% | -360.2% | 10.2% | -905.7% | 0.0% | -6000.8% |
| Net Margin | 0.0% | -345.4% | 12.9% | -892.4% | 0.0% | -6504.6% |
| EBITDA Margin | 0.0% | -333.0% | 10.5% | -903.5% | 0.0% | -6000.6% |
| Liquidity | ||||||
| Current Ratio | 14.27x | 6.67x | 5.66x | 8.20x | 6.03x | 1.86x |
| Quick Ratio | 14.27x | 6.67x | 5.20x | 7.99x | 6.03x | 1.86x |
| Leverage | ||||||
| Debt/Equity | 0.02x | 0.01x | 0.01x | 0.02x | 0.00x | -0.02x |
YoY = year-over-year change. Source: FMP..